From 1 - 10 / 254
  • Categories    

    Re-emergence of pertussis despite high vaccination coverage in western countries, results in increased risk for severe and even fatal pertussis among newborns. For this reason, late 2015 the Dutch Health Council (HC) advised to offer 3rd trimester pertussis vaccination to pregnant women. At the start of the maternal pertussis programme late 2019, the maternal Tdap was advised from 22w of gestation onwards. Preterms, accounting for 8% of newborns in the Netherlands, are at highest risk for severe pertussis leading to prolonged hospital and intensive care admissions and sometimes death. Recently, it has become evident that despite 3rd trimester vaccination, preterms remain at high risk because the vaccination is likely given too late for sufficient antibody transfer. For this vulnerable group 2nd trimester vaccination may offer better protection because of extended time for antibody transfer. To date, most countries recommend 3rd trimester vaccination to protect young, not yet (fully) vaccinated infants. Data from England show 91% effectiveness against infant pertussis after maternal Tetanus- diphtheria -acellular Pertussis (Tdap) vaccination in the 3rd trimester. Studies focussing on preterms and protection after maternal vaccination are scarce. Two observational studies reported on effectiveness and antibody levels in cord blood of 2nd trimester vaccination in term infants. While one study showed significantly higher antibody levels after 2nd trimester vaccination (13-25 gestational weeks; GW), another study showed decreased effectiveness of 2nd trimester (<27 GW) vaccination. Only one study concerned antibody transfer in preterms and reported higher antibody levels after 2nd (n=37) than after 3rd (n=48) trimester vaccination. Aiming to contribute to setting optimal vaccine strategy of maternal pertussis vaccination in the Netherlands and elsewhere and particular for the most vulnerable group of preterms, we propose a study that compares pertussis antibody levels in preterms and terms after 2nd trimester maternal vaccination. We can compare these to data we have on 3rd trimester Tdap in terms. In addition to adequate antibody levels, success of 2nd trimester vaccination depends on acceptance of this strategy by pregnant women and professionals. Our primary endpoint is IgG anti-pertussis toxin (Pt) antibody concentration in preterms and terms at 2m of age, Pt is considered the most relevant antibody for protection against clinical pertussis. Secondary endpoints are e.g. pertussis specific antibody concentrations in preterms and terms in cord blood and in women at delivery. Determinants of acceptance of 2nd trimester maternal vaccination are also a secondary endpoint. Antibody concentrations will be assessed in serum, using a fluorescent bead-based multiplex immunoassay, with required blood volume of minimal 100µl. For the survey on acceptance, we aim to have 4 groups of 100 women each, i.e. women who are pregnant for the 1st time, women who already gave birth and in both groups women with and without a known increased risk of preterm delivery. For the immunogenicity part, we aim to have at least 60 preterms and 60 terms, as this is, according to experts, the minimum number to enable good comparisons. Pregnant women will be offered 2nd trimester pertussis vaccination. Both among acceptors and non-acceptors acceptance of 2nd trimester vaccination will be assessed. Women are first asked to participate in the acceptance part after the 1st antenatal visit to a midwife or obstetrician. They fill in a questionnaire to assess behavioral determinants and beliefs that underlie acceptance of 2nd trimester maternal vaccination. Only after this consent, women will be asked to participate in the immunogenicity part. Hereby, women will receive Tdap after they have the 20w standard anomaly ultrasound scan (20-24 GW). Vaccinated women will be followed until delivery. All preterms and a random selection of 60 terms, all of vaccinated mothers, will be followed until 2m of age, i.e. just before start of the NIP. By including both women in primary and secondary antenatal care, we aim to enrich our study population with women who are at increased risk for preterm delivery, as these women are usually seen by an obstetrician. Data from our study will determine whether 2nd trimester Tdap leads to sufficient Pt antibodiy concentration in terms and preterms compared to 3rd trimester vaccination. Furthermore, we will have knowledge about obstacles for acceptance and can tailor information for all pregnant women to overcome these. Finally, given that in near future besides pertussis other maternal vaccines are likely to become available for prevention of severe disease in newborns (RSV, GBS), in particular in preterms, this study generates essential knowledge for future vaccine policy of maternal vaccines.

  • Categories  

    Op de kaart ziet u welk percentage van de bevolking in de door u gekozen gemeente ernstig gehinderd is door geluid van zijn of haar buren.

  • Categories    

    Deze kaart toont de gemodelleerde concentratie fijn stof (µg PM10/m³) voor 2020 op basis van rekenpunten uit de monitoringstool van het nsl. Deze vlakdekkende kaart van Nederland heeft een resolutie van 25 meter.

  • Categories  

    genexpressie in stamcellen na blootstelling aan verschillende concentraties ftalaten

  • Categories  

    Genexpressie in longen van volwassen en oude muizen na infectie met RSV

  • Categories  

    Wat ziet u? De kaart brengt populaties van bomen en struiken in beeld die een bepaalde genetische waarde vertegenwoordigen voor deze soorten in Nederland. De kaart geeft een overzicht van de populaties die belangrijk zijn voor bescherming van genetische diversiteit van de soort binnen Europa: zogenaamde conservation units. Wat is de waarde? De populaties vertegenwoordigen vanwege hun bijzonder genetische samenstelling een bepaalde economische waarde en/of ecologische waarde. De populaties kunnen van belang zijn voor een productie doelstelling (productie van kwalitatief goed hout) of ecologische doelstelling (teeltmateriaal vertegenwoordigt een ecologisch waarde, ook wel autochtoon plantmateriaal genoemd) Voor wie is dit belangrijk? Beheerders van natuur-, bos en landschappelijke beplantingen, kwekers.

  • Categories  

    Fijnstof (PM2.5) emissies naar lucht uit alle bronnen in 2014 in kg per jaar. Emissieregistratie 1990 - 2014 (vastgesteld 2016).

  • Categories    

    In deze kaart zijn de meetlocaties te zien die door het RIVM bemonsterd zijn ten behoeve van het onderzoek naar de afleiding van de definitieve achtergrondwaarde PFAS in landbodem. De kaart laat meetwaarden zien van PFOA in de diepere bodemlaag (50 - 100 cm) in potentieel beïnvloede gebieden. Omdat de afleiding van de definitieve achtergrondwaarden is gebaseerd op de toplaag van de onbeïnvloede landbodem, zijn deze meetwaarden niet meegenomen in de afleiding van de definitieve achtergrondwaarde.

  • Categories  

    RNAseq op zebravisembryos en zebravislever

  • Categories  

    Zoet oppervlaktewater wordt door de landbouw gebruikt voor beregening van landbouwgewassen. Hiervoor is binnen Deltaprogramma zoet water bepaald wat de totale hoeveelheid water is die aangevoerd kan worden en wat het uiteindelijke tekort aan zoet water voor dit doeleinde is. De resultaten kunnen gepresenteerd worden voor 5 deelgebieden waaruit Nederland is opgebouwd in de sommen die Deltaprogramma zoet water heeft laten uitvoeren. De Waddeneilanden maken geen onderdeel uit van de analyses. (getallen in m3/zomerhalfjaar). De kaart geeft het watertekort voor beregening in een droog jaar weer, zoals berekend door Deltaprogramma Zoet Water met behulp van NHI (Nederland Hydrologisch Instrumentarium)